verapamil has been researched along with Ventricular Dysfunction in 6 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Ventricular Dysfunction: A condition in which HEART VENTRICLES exhibit impaired function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our results did not demonstrate a benefit derived from the treatment with verapamil upon the diastolic function in patients with acromegaly." | 9.10 | [Utility of verapamil in the treatment of diastolic dysfunction in patients with acromegaly]. ( Climent Payá, VE; Marín Ortuño, F; Martínez Martínez, JG; Picó Alfonso, AM; Sánchez Payá, J; Sogorb Garri, F, 2003) |
| "The mechanisms of digoxin-induced ventricular arrhythmias were studied in vivo using a novel experimental model." | 7.69 | Digoxin-induced ventricular arrhythmias in the guinea pig heart in vivo: evidence for a role of endogenous catecholamines in the genesis of delayed afterdepolarizations and triggered activity. ( Hurt, CM; Pelleg, A; Xu, J, 1995) |
| "In young children with incessant ventricular tachycardia and severe ventricular dysfunction, the management of tachycardia with conventional antiarrhythmic drugs remains a major therapeutic challenge because most of these drugs can further depress myocardial function." | 5.30 | Verapamil responsive incessant ventricular tachycardia resulting in severe ventricular dysfunction in a young child: successful management with oral verapamil. ( Cho, JG; Kim, BJ; Ma, JS, 1997) |
| "Our results did not demonstrate a benefit derived from the treatment with verapamil upon the diastolic function in patients with acromegaly." | 5.10 | [Utility of verapamil in the treatment of diastolic dysfunction in patients with acromegaly]. ( Climent Payá, VE; Marín Ortuño, F; Martínez Martínez, JG; Picó Alfonso, AM; Sánchez Payá, J; Sogorb Garri, F, 2003) |
| "The mechanisms of digoxin-induced ventricular arrhythmias were studied in vivo using a novel experimental model." | 3.69 | Digoxin-induced ventricular arrhythmias in the guinea pig heart in vivo: evidence for a role of endogenous catecholamines in the genesis of delayed afterdepolarizations and triggered activity. ( Hurt, CM; Pelleg, A; Xu, J, 1995) |
| "In young children with incessant ventricular tachycardia and severe ventricular dysfunction, the management of tachycardia with conventional antiarrhythmic drugs remains a major therapeutic challenge because most of these drugs can further depress myocardial function." | 1.30 | Verapamil responsive incessant ventricular tachycardia resulting in severe ventricular dysfunction in a young child: successful management with oral verapamil. ( Cho, JG; Kim, BJ; Ma, JS, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marín Ortuño, F | 1 |
| Climent Payá, VE | 1 |
| Picó Alfonso, AM | 1 |
| Martínez Martínez, JG | 1 |
| Sánchez Payá, J | 1 |
| Sogorb Garri, F | 1 |
| Aydin, O | 1 |
| Becker, R | 1 |
| Kraft, P | 1 |
| Voss, F | 1 |
| Koch, M | 1 |
| Kelemen, K | 1 |
| Katus, HA | 1 |
| Bauer, A | 1 |
| Xu, J | 1 |
| Hurt, CM | 1 |
| Pelleg, A | 1 |
| Conti, CR | 1 |
| Ma, JS | 1 |
| Kim, BJ | 1 |
| Cho, JG | 1 |
| Molinero, E | 1 |
| Murga, N | 1 |
| Sagastagoitia, JD | 1 |
| Fernández, R | 1 |
| Garrido, J | 1 |
1 review available for verapamil and Ventricular Dysfunction
| Article | Year |
|---|---|
Re-examining the clinical safety and roles of calcium antagonists in cardiovascular medicine.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Cardiovascular Diseases; Cor | 1996 |
2 trials available for verapamil and Ventricular Dysfunction
| Article | Year |
|---|---|
[Utility of verapamil in the treatment of diastolic dysfunction in patients with acromegaly].
Topics: Acromegaly; Aged; Calcium Channel Blockers; Diastole; Female; Humans; Male; Middle Aged; Ventricular | 2003 |
Treatment of diastolic dysfunction in hypertensive patients without left ventricular hypertrophy.
Topics: Adult; Aged; Amiloride; Anti-Arrhythmia Agents; Antihypertensive Agents; Diuretics; Drug Therapy, Co | 1998 |
3 other studies available for verapamil and Ventricular Dysfunction
| Article | Year |
|---|---|
Effects of protein kinase C activation on cardiac repolarization and arrhythmogenesis in Langendorff-perfused rabbit hearts.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Electrophysiologic Techniques, Cardiac; Enzyme A | 2007 |
Digoxin-induced ventricular arrhythmias in the guinea pig heart in vivo: evidence for a role of endogenous catecholamines in the genesis of delayed afterdepolarizations and triggered activity.
Topics: Adenosine; Analysis of Variance; Animals; Arrhythmias, Cardiac; Catecholamines; Digoxin; Disease Mod | 1995 |
Verapamil responsive incessant ventricular tachycardia resulting in severe ventricular dysfunction in a young child: successful management with oral verapamil.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Child, Preschool; Echocardiography; Humans; Male; Tach | 1997 |